Skip to main content

Establishment profile

GERI-CARE PHARMACEUTICALS CORP.

1673 63RD STREET, BROOKLYN, NY, 11204
424210Drugs and Druggists' Sundries Merchant Wholesalers

Download as PDF →

OSHA inspections
1
over 14 years
Violations
2
$3,696 in penalties
Penalties
$3,696
$1,848 avg

Summary

GERI-CARE PHARMACEUTICALS CORP. has accumulated 2 OSHA violations across 1 inspection over 14 years of recorded history, with $3,696 in total assessed penalties.

The most recent federal enforcement activity was recorded 14 years ago.

Federal records were found in 1 of 15 sources. Sources without matching records returned empty for this establishment.

Agency coverage

GERI-CARE PHARMACEUTICALS CORP. appears in OSHA workplace safety and CPSC product recalls records only. No matching records were found in WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, OFLC visa and labor certification (historical), FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, or NHTSA vehicle recalls.

OSHA workplace safety

Inspections
1
0.1 / yr · last 14 yrs
Violations
2
0.1 / yr
Penalties
$3,696
$1,848 avg / violation
100% serious0% other
Inspection trigger · complaint
1 of 1

100% of inspections at this establishment produced violations,

Most-cited OSHA standards

Top OSHA standards cited at this employer, ranked by citation count. Standards (CFR sections) cluster citations into safety themes -- machine guarding, lockout-tagout, hazard communication, fall protection, process safety, etc. A concentration on one or two sections reveals a pattern that individual citations don’t. 2 distinct standards shown · 2 citations in this view · $3,696 in penalties.

CFR sectionCitationsInspectionsTotal penaltyFirst citedLast cited
29 CFR 1910.0157 G0111$1,848Dec 2011Dec 2011
29 CFR 1910.0305 G01 III11$1,848Dec 2011Dec 2011

Source: OSHA inspection citations (violation_detail). CFR section codes can be looked up at osha.gov/laws-regs for the formal standard text. Per-inspection detail and the specific violation descriptions are available by expanding individual inspections below.

Safety self-report (OSHA 300A)

No self-reported injury rates filed with OSHA's Injury Tracking Application for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with OSHA Injury Tracking Application

Industry benchmark

Industry avg TRIR
1.3
BLS SOII 2024
Industry avg DART
1.0
BLS SOII 2024
Self-reported TRIR
Not in OSHA ITA

BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.

Inspection breakdown

Complaint
1

Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.

OSHA severe injury reports

No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with Occupational Safety and Health Administration

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
14 years ago

No federal enforcement activity has been recorded against this establishment in 14+ years. Most recent activity: 14 years ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

No NLRB unfair labor practice charges or union representation cases on file for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with National Labor Relations Board

Visa & labor certification (OFLC) — historical

No H-1B, H-2A, or H-2B labor condition applications on file (historical data only — DOL ended OFLC publication) for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with Office of Foreign Labor Certification

Environmental compliance (EPA)

No EPA inspections or formal enforcement actions on file for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with Environmental Protection Agency

Federal criminal prosecution record

No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for GERI-CARE PHARMACEUTICALS CORP.. Verify directly with UVA Corporate Prosecution Registry

CPSC product recalls

Total recalls
1
Last 5 years
1
Last 12 months
0
Units recalled
0

Top hazard: The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.. Most recent recall: 2022-01-26. Source: Consumer Product Safety Commission, matched on company name.

CPSC recall roster

Every CPSC consumer-product recall associated with this manufacturer, most-recent first. Hazards reflect CPSC’s classification (laceration, fire, fall, choking, lead exposure, etc.). Each row links to the agency’s authoritative recall page for the full remedy / contact / recall-number detail. 1 recall shown · 1 distinct hazard categories.

RecallDateHazardsUnitsCPSC
Geri-Care Pharmaceuticals Recalls Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
#22060
Jan 2022The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.View →

Source: Consumer Product Safety Commission. Recall details (specific products, sale dates, remedy instructions) live on the cpsc.gov record linked from each row.

Inspection history

DateTriggerViolationsSeriousPenalty
2011-07-27Complaint22$3,696

Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.

In the news

Other employers in this industry and state

Other employers in drugs and druggists' sundries merchant wholesalers within NY, ordered by federal enforcement volume:

Related searches

About this data

This profile aggregates federal enforcement records on GERI-CARE PHARMACEUTICALS CORP. from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

Frequently asked

What is GERI-CARE PHARMACEUTICALS CORP.'s OSHA violation history?
GERI-CARE PHARMACEUTICALS CORP. has 1 OSHA inspection on record with 2 violations and $3,696 in total penalties.
How does GERI-CARE PHARMACEUTICALS CORP.'s safety record compare to its industry?
GERI-CARE PHARMACEUTICALS CORP. operates in the drugs and druggists' sundries merchant wholesalers industry. The industry average Total Recordable Incident Rate (TRIR) is 1.3.